Why Centene may have switched from CVS Caremark to Cigna's Express Scripts

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES With PBM satisfaction on the decline, Centene switches to Express Scripts Centene is swapping CVS Caremark with Express Scripts. A recent survey that measured benefit leaders' satisfaction with their PBMs found that Express Scripts performed better than CVS Caremark. Sponsored Content Inflation's impact on healthcare switchboards and call centers From Parlance and MedCity News Hospitals struggle to retain switchboard and call center staff, a situation exacerbated by inflation. Here's how Parlance is leveraging its call automation tech to help address these needs and improve the caller experience. Medtronic serves up platform for stroke-care startups By Joel Berg Friday, October 28, 2022 3:32 PM The innovation platform promises to match entrepreneurs with the resources they need to advance treatments for stroke care but also to help the device maker process all the new ideas it sees. Read more » House report finds PBMs and insurers aren't covering birth control like ACA requires By Amanda James Friday, October 28, 2022 2:01 PM The investigation also found that companies denied exceptions requests on average four or more times out of ten, raising barriers to accessing birth control, according to a news release on Tuesday. Read more » 5 years after FDA approval, CAR-T treatment looks like the future of medicine By Bruce A. Feinberg Friday, October 28, 2022 2:00 PM CAR-T has become increasingly recognized as an exciting and potentially paradigm-shifting treatment in the past five years. In fact, more than 10,000 patients have undergone this new treatment for certain types of leukemia, lymphoma and multiple myeloma. Read more » Sanofi hits reset on drug from $2.5B deal after 'lower than projected' efficacy in trials By Frank Vinluan Friday, October 28, 2022 1:14 PM Sanofi did not see the efficacy it wanted in mid-stage tests of a cytokine therapy from its $2.5 billion acquisition of Synthorx. While the pharmaceutical giant isn't giving up on the drug, it said it will restart the molecule in a new Phase 1/2 program, a setback that will lead to a €1.6 billion financial writedown. Read more » Hazel Health raises $51.5M to scale school-based telehealth By Katie Adams Friday, October 28, 2022 10:36 AM Hazel Health, a company that provides school-based telehealth, has closed a $51.5 million Series C1 funding round. The company also announced it has deployed its services in more than 3,000 schools across 14 states. Read more » Patient identity: The keystone that many strategic initiatives don't realize is required — until it's too late By Gevik Nalbandian Friday, October 28, 2022 9:00 AM When you don't know your patients well, you risk compromising their care, trust, and business. There is limited capability to address health equity and effectively adopt value-based care models if an organization does not prioritize identity management. Read more » Guide to Pharmaceutical Contract Management Excellence Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape. Download this FREE eBook to learn more! MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails